We deliver strategic recommendations that elevate brands
We asked our clients to describe us and they said we are intelligent, trusted and customer-led
We provide socialised insights and recommendations that impact brands.
We love what we do and continuously strive for innovation and creativity.
We are independent, quick to respond and embrace new ideas.
We work in partnership with clients and bring the best minds to the team.
Our insights are based on rigorous research methods.
*2017-18 Project feedback survey
Our people »
“Your results have driven key decision making which is now translating into very good performance for our brand, so well done”Commercial Analysis Manager
“I would like to thank all of you for the excellent work you did and all the support provided. Your expertise and professionalism was highly appreciated, as were the provided results. I’m already looking forward to the next possibility to work with you.”International Business Analyst
“Working on large-scale quantitative studies with the team at the Research Partnership over the last 4 years has been a positive collaboration. They have been excellent to work with and have helped set out realistic expectations for research projects, asking insightful questions during the setup process, giving guidance to sampling and quotas and also mapping timelines to ensure that the work meets company objectives. The team's experience in managing large and multi-market quant studies, and also their responsive attitude, has been a major factor contributing to the success of projects. It is always a pleasure working with RP team on quantitative studies.”Associate Director, Global Business Intelligence
“I just want to thank you for the recent project you ran very successfully. The report delivered was high quality, definitely bringing new insights and ways to look at our marketing issue. It was also clear at the presentation that you had a deep understanding of the disease area. Very good job!”Director, Business Analysis
- Some example case studiesHow we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatment
The challenge: Our client is a recently established independent biopharmaceutical company specialising in small molecule development. They were developing a new oral compound for the treatment of a rare genetic disease for which the standard treatment is administered intravenously, however a large proportion of patients receive monitoring only or remain undiagnosed. Their objective was to successfully launch their product in order to provide clinically meaningful…read more »How we helped track and evaluate conference performance over time across multiple international events
Our client planned to have a significant presence at key global conferences over the course of a year. Find out how we effectively monitored perceptions of their brand across different regions over time.read more »How we used behavioural economic theory to reveal fresh insights into patient compliance
Our client currently has a product for a chronic rare disease which has seen an initial successful uptake. HCPs appear to support the product and are actively prescribing it to suitable patients.read more »